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Essential Role of Type I
Phosphatidylinositol 4-Phosphate
5-Kinase in Neurite Remodeling
ent substrates [9]. The Type I family, which is composed
of three isoforms [3], is a PtdIns(4)P-5-kinase and has
been shown to act downstream of both Rac- [10] and
RhoA-dependent [4] pathways in the regulation of the
actin cytoskeleton [6, 7, 11]. To investigate the role of
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Plesmanlaan 121 PtdIns(4,5)P2 in neurite remodeling, we introduced Type
I and Type II PIPkinases in N1E-115 neuroblastoma1066 CX Amsterdam
The Netherlands cells.
When exposed to serum-free conditions, N1E-1152 Immuno-endocinology
ENVN cells flatten and extend neurites. The addition of LPA,
S1P, or thrombin, acting on their cognate G protein-Atlanpole La Chantrerie
BP 40706, 44307 coupled receptors, leads to the rapid retraction of neu-
rites and cell contraction [2]. As shown in Figure 1A,Nantes cedex 03
France transfection of Type I PIPkinase into these cells led
to neurite retraction and cell body contraction in the3 Molecular Neurobiology Group
GKT School of Medicine absence of serum. As Type I PIPkinase regulates the
cellular levels of both PtdIns(4,5)P2 and PtdIns(3,4,5)P3King’s College London
London SE1, 9RT [12], we used the Type II PIPkinase, which is also able
to synthesize PtdIns(4,5)P2 in vivo. Transfection of thisUnited Kingdom
enzyme, however, had no effect on cell morphology.
Confocal microscopy studies revealed that the Type
II PIPkinase was expressed, but that it resided in theSummary
cytosol and therefore was unlikely to regulate the levels
of PtdIns(4,5)P2 (Figure 1B). To overcome this, it wasRapid neurite remodeling is fundamental to nervous
system development and plasticity [1] and is regulated targeted to the plasma membrane using the myristoyla-
tion/palmitoylation sequence from the Src family tyro-by Rho family GTPases that signal f-actin reorganiza-
tion in response to various receptor ligands. Neuronal sine kinase Fyn. Confocal microscopy showed that myri-
stoylation-induced targeting led to plasma membraneN1E-115 cells show dramatic neurite retraction and
cell rounding in response to serum factors such as localization (Figure 1B) and an increase in cell contrac-
tion, a similar phenotype as that induced by the Typelysophosphatidic acid (LPA), sphingosine-1 phosphate
(S1P), and thrombin, due to activation of the RhoA- I PIPkinase. As PtdIns(4,5)P2 is the only common phos-
phatidylinositol lipid to be synthesized by these en-Rho kinase pathway [2]. Type I phosphatidylinositol
4-phosphate 5-kinases (PIPkinase), which regulate zymes, these data suggest that increased PtdIns(4,5)P2
levels are required for neurite remodeling.cellular levels of PtdIns(4,5)P2 [3], have been suggested
as targets of the RhoA-Rho kinase pathway [4, 5] able
to modulate cytoskeletal dynamics [6, 7]. Here, we
Neurite Retraction and Cell Rounding Inducedshow that the introduction of Type I PIPkinase into
by Type I PIPkinase Occurs DownstreamN1E-115 cells leads to cell rounding and complete
of RhoA, Rho Kinase, and Myosininhibition of neurite outgrowth, perhaps through the
Light Chain Kinasedissociation of vinculin and the destabilization of focal
LPA-induced neurite retraction and cell rounding in N1E-adhesions. This occurs independently of RhoA, Rho
115 cells is mediated by the activation of RhoA andkinase, and the activation of actomyosin contraction.
its downstream effector Rho kinase [2]. Although dataStrikingly, expression of kinase-dead PIPkinase pro-
suggest that PIPkinase acts downstream of RhoA, ge-motes the outgrowth of neurites, which fail to retract
netic evidence from yeast suggests that it lies upstreamin response to LPA, S1P, thrombin, or active RhoA.
[13], and biochemical data suggest that phosphoinosi-Moreover, neurite retraction in response to an endoge-
tides are able to modulate the interaction between RhoAnous neuronal guidance cue, Semaphorin3A, was also
and its inhibitor RhoGDI. We investigated if Type I PIP-dependent on Type I PIPkinase. Our results suggest
kinase-induced rounding is dependent on the RhoA-an essential role for a Type I PIPkinase during neurite
Rho kinase pathway. Transfection of dominant-negativeretraction in response to a number of diverse stimuli.
RhoA (RhoN19) completely inhibits LPA-induced neurite
retraction. Surprisingly, Type IPIPkinase-mediated cellResults and Discussion
rounding was not inhibited by cotransfection of this
dominant-negative form of RhoA (Figure 2A). In accor-Type I PIPkinase Overexpression Leads to
dance with PtdIns(4,5)P2 synthesis lying downstream ofNeurite Retraction and Cell Rounding
the activation of RhoA in neurite remodeling, myristoy-The levels of PtdIns(4,5)P2 are regulated by Type I and
Type II PIPkinases [3, 8], which phosphorylate two differ- lated Type II PIPkinase-induced rounding was also not
inhibited by RhoN19 (Figure 2A). We found that PIP-
kinase expression in Cos-7 cells does not induce RhoA-4 Correspondence: ndivecha@nki.nl
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Figure 1. Type I PIPkinase and Myristoylated Type II PIPkinase
Inhibit Neurite Outgrowth
(A) N1E-115 cells were transfected with either Lac Z alone or with
Type I PIPkinase, Type II PIPkinase, or myristoylated Type II
PIPkinase (ratio 1:5). Cells were cultured in serum-free medium over-
night, and morphology was assessed as described (see the Supple-
mentary Material available with this article online). The results shown
are representative of four experiments, each performed in triplicate.
(B) Immunolocalization of Type II PIPkinase. N1E-115 cells were Figure 2. Type I PIPkinase- and Myristoylated Type II PIPkinase-
transfected with Type II PIPkinase or myristoylated Type II PIP- Induced Rounding Is Independent of RhoA, ROCK, and Myosin Light
kinase. Cells were grown in serum-free medium overnight and Chain Kinase Activity
stained using a mix of rat monoclonal antibodies directed against N1E-115 cells were transfected with (A) Lac Z or (B and C) GFP with
bovine brain Type II PIPkinase. Type II PIPkinase is mainly cyto- RhoN19, Type I, Type II, or myristoylated Type IIPIPkinase. Cells
solic, with some staining present in the nucleus. Fusion of the Fyn- were cultured in serum-free medium overnight, and morphology was
myristoylation/palmitoylation sequence leads to predominantly assessed (see the Supplementary Material). The results shown are
membrane-bound staining. representative of three experiments, each performed in triplicate.
(A) Coexpression of RhoN19 has no effect on Type I- or Type II
PIPkinase-induced neurite retraction.
(B) Pretreatment of N1E-115 cells with Y-27632 (50 M, 30 min)GTP formation, in contrast to LPA and the DH/PH do-
inhibits LPA-induced (1 M, 3 min), but has no effect on, Type Imain of p190RhoGEF [14] (data not shown). Pretreat-
PIPkinase-induced neurite retraction.ment of the cells with Y-27632, a specific inhibitor of
(C) Pretreatment of N1E-115 cells with K252-a (0.5 M, 30 min)Rho kinase, completely blocked neurite retraction in-
inhibits LPA-induced (1 M, 3 min), but has no effect on, Type I
duced by LPA but had no effect on cell rounding induced PIPkinase-induced neurite retraction.
by Type I PIPkinase (Figure 2B). These data support
the hypothesis that the activation of Type I PIPkinase
lies downsteam of both RhoA-Rho kinase during neurite binds to, and influences the activity of, several actin-
associated proteins in vitro, including focal adhesionremodeling.
LPA and RhoA-induced cell rounding in N1E-115 cells molecules such as vinculin and members of two families
of proteins, ERM and WASP. These proteins are regu-depends on the generation of actomyosin contractile
forces and is blocked by K-252a, an inhibitor of myosin lated by the interplay between Rho GTPases and
PtdIns(4,5)P2 metabolism and thus link the plasma mem-light chain kinase (Figure 2C). However, Type I PIP-
kinase-induced rounding was not inhibited by K-252a, brane with cytoskeletal remodeling [15]. The regulation
of focal adhesion proteins such as vinculin during neu-suggesting that induction of rounding by PtdIns(4,5)P2
does not require actomyosin-mediated force gener- rite outgrowth has been demonstrated [16], and its im-
portance is exemplified by strongly reduced neurite out-ation.
growth in vinculin-deficient PC12 cells [17] and reduced
neural development in vinculin-deficient mice [18]. Con-Type I PIPkinase Induces the Loss of Vinculin
from Focal Adhesions versely, neurite outgrowth in N1E-115 cells is promoted
by increased cell adhesion.The mechanism behind Type IPIPkinase-induced neurite
retraction and cellular rounding is unclear. PtdIns(4,5)P2 To investigate the role of Type I PIPkinase in focal
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adhesion regulation, we microinjected single cells with
Type I PIPkinase cDNA, and focal adhesion compo-
nents were assessed using immunofluorescence at
early time points after overexpression. In these experi-
ments, we used endothelial PAE cells, since the viability
of N1E-115 cells after microinjection is very low. Type
I PIPkinase was expressed as early as 1 hr after micro-
injection. However, after 4 hr, the cells began to detach
and round up. Retraction was not seen with an inactive
version of Type IPIPkinase, which has a point mutation
in the ATP binding site, leading to less than 1% of the
wild-type protein activity [12]. These results suggest
that overexpression of Type I PIPkinase may lead to
a disruption of cell-matrix interaction (Figure S1).
To examine which component of focal adhesions
might be regulated by the Type IPIPkinase, we studied
the localization of vinculin, paxillin, and focal adhesion
kinase (FAK) after microinjection of the Type I PIP-
kinase, when cells were still attached and flat. Strikingly,
overexpression of the Type IPIPkinase led to a redistri-
bution of vinculin from the focal adhesions. This did not
represent the general destruction of focal adhesions as,
at this time point, both paxillin and FAK were still present
(Figure 3A). No changes in the localization of vinculin
with focal adhesions were seen when the kinase-dead
Type I PIPkinase was microinjected (Figure 3B). These
results suggest that enhanced PtdIns(4,5)P2 production
stimulates vinculin redistribution and the dissociation
of focal adhesion complexes, eventually leading to cell
rounding.
Dominant-Negative Type I PIPkinase Promotes
Neurite Elongation and Inhibits LPA-Induced
Neurite Retraction
To unequivocally demonstrate that Type I PIPkinase
is required during LPA-mediated neurite retraction and
cell rounding, we attempted to inhibit this response us-
ing a dominant-negative mutant of the Type I PIP-
kinase. N1E-115 cells were transiently transfected with
Figure 3. Type I PIPkinase Induces the Loss of Vinculin from FocalGFP or GFP-tagged kinase-dead Type I PIPkinase.
AdhesionsStrikingly, overexpression of the inactive Type I PIP-
(A) PAE cells were microinjected with EE-tagged Type I PIPkinase,kinase led to prominent neurite outgrowth (Figure 4A),
left for 3 hr, and then fixed and stained for the presence of Type Ireminiscent of what is observed after RhoA inactiva-
PIPkinase and vinculin, paxillin, or focal adhesion kinase (p125FAK)
tion [19]. as indicated. In the lower panel, Type I PIPkinase was injected
We then tested if the neurites induced by expression together with a fluorescent dye to mark the injected cell. The upper
of the mutant Type I PIPkinase were still responsive panels show that, before injection, vinculin is present in focal adhe-
sion complexes. However, 3 hr after the injection of active Type Ito LPA. In cells expressing the kinase-inactive Type I
PIPkinase, the presence of vinculin within focal adhesion complexesPIPkinase, retraction induced by LPA was completely
is highly diminished. (The merged panel shows that the detectedinhibited (Figures 4A and 4B). Neurites induced by domi-
vinculin staining does not localize to the Type I PIPkinase-express-
nant-negative PIPkinase were also resistant to S1P- and ing cells.) In contrast, paxillin and FAK are still present at this time
thrombin-induced retraction (Figure 4B). Cooverexpres- point (middle and lower panels).
sion of wild-type Type I PIPkinase completely sup- (B) PAE cells were microinjected with a kinase-dead (KD) EE-tagged
Type I PIPkinase, left for 3 hr, and stained for vinculin and Typepressed the dominant-negative effect of the inactive
I PIPkinase as indicated. Note that vinculin is still present withinType I PIPkinase (Figure S2). We also found that the
the focal adhesions.inactive PIPkinase completely inhibits rounding induced
by constitutively active RhoA (RhoV14, Figure 4C). In
agreement with a role for Type IPIPkinase in the regula-
well-established neuronal axon guidance molecules ex-tion of focal adhesion diassembly rather than actomyo-
hibiting both repulsive and attractant activities on differ-sin-based contraction, vinculin is still present in focal
ent neurons in vivo. We found that Semaphorin 3A, aadhesions in N1E-115 cells expressing the kinase-dead
repulsive axon guidance cue [20], is able to induceType IPIPkinase after stimulation with LPA (Figure 4D).
In contrast to LPA, TRP, and S1P, Semaphorins are rounding in N1E-115, which is also inhibited by expres-
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Figure 4. Dominant-Negative Type I PIPkinase Induces Neurite Formation and Inhibits LPA-, TRP-, S1P-, and Sema3A-Induced Neurite
Retraction
(A) N1E-115 cells were transfected with GFP alone or with kinase-dead (KD) GFP-tagged Type I PIPkinase as indicated. Cells were cultured
in serum-free medium overnight and maintained as controls or were stimulated with LPA (1M, 3 min). Under conditions of serum starvation
alone, N1E-115 cells do not normally extend long neurites. However, transfection of an inactive GFP-Type I PIPkinase led to the appearance
of long extended neurites that failed to retract in response to LPA.
(B) Cells were transfected as indicated and were stimulated with either LPA (1 M), thrombin receptor peptide (TRP, 12.5 M), or sphingosine-
1-phosphate (S1P, 200 nM) for 3 min or Semaphorin3A (Sema3A, 1 g/ml) for 10 min. The percentage of contracted cells was calculated and
is shown graphically. The results shown are representative of three experiments, each performed in triplicate. Kinase-inactive Type I PIPkinase
blocks LPA-, TRP-, and S1P-, as well as the Sema3A-induced contraction of N1E-115 cells.
(C) N1E-115 cells were transfected with GFP and RhoV14 or with kinase-inactive GFP Type I PIPkinase and RhoV14. As can be seen, RhoV14
induces rounding in cells when transfected with GFP; however, cotransfection with the kinase-inactive Type I PIPkinase blocks RhoV14-
induced neurite retraction.
(D) N1E-115 cells were transfected with kinase-dead (KD) GFP-tagged Type I PIPkinase and were cultured in serum-free medium overnight.
Cells were stimulated with LPA (1 M, 3 min) and were fixed and stained for vinculin. As can been seen, no rounding or detachment has
occurred, and vinculin is still present within the focal adhesion complexes.
sion of the dominant-negative Type I PIPkinase (Fig- receptor ligands, leads not only to actomyosin contrac-
tion, but also to the concurrent modulation of integrin-ure 4B).
These data are consistent with the notion that neurite extracellular matrix interaction through the action of a
Type I PIPkinase. This notion is supported by a recentremodeling induced by various receptor ligands requires
modulation of a Type I PIPkinase activity. This require- study, which shows that tail retraction in migrating
monocytes is dependent on the RhoA-Rho kinase path-ment appears to be regulated through a RhoA-mediated
pathway, consistent with a Type I PIPkinase acting way and that inhibition of tail retraction occurs through
enhanced integrin-mediated adhesion, suggesting adownstream of RhoA [4]-Rho kinase [5]. The demonstra-
tion that Type I PIPkinase-induced rounding in neu- new role for RhoA in the negative regulation of the integ-
rin-substratum interaction [23]. The stimulation of neu-ronal cells is not inhibited by a myosin light chain kinase
inhibitor suggests that, although PIPkinase may lie rite outgrowth induced by the dominant-negative PIP-
kinase is difficult to explain, however. It is possible thatdownstream of RhoA, it does not induce rounding through
enhanced actomyosin contraction. Type I PIPkinase blocking focal adhesion dissolution promotes neurite
elongation. Induction of neurite outgrowth also occursactivity does, however, appear to regulate the associa-
tion of vinculin with focal adhesions, consistent with with dominant-negative mutants of RhoA and Rho ki-
nase in N1E-115 cells [19] and primary neurons [24].previous data showing a role for phosphoinositides in
the regulation of vinculin [21] and of focal adhesions The observation that receptor-mediated neurite re-
traction is completely inhibited by a dominant-negative[22]. We suggest that the regulation of RhoA, by various
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MSS4, a phosphatidylinositol-4-phosphate 5-kinase requiredType I PIPkinase underscores the importance of this
for organization of the actin cytoskeleton in SaccharomycesPtdIns(4,5)P2 in the regulation of neurite remodeling. It
cerevisiae. J. Biol. Chem. 273, 15787–15793.is likely that, in a growing axon, regulation of Type I
14. van Horck, F.P., Ahmadian, M.R., Haeusler, L.C., Moolenaar,
PIPkinase is required during both collapse and elonga- W.H., and Kranenburg, O. (2001). Characterization of p190Rho-
tion of the growth cone, processes that dictate the guid- GEF, a RhoA-specific guanine nucleotide exchange factor that
interacts with microtubules. J. Biol. Chem. 276, 4948–4956.ance of axons to their targets during development.
15. Miki, H., Miura, K., and Takenawa, T. (1996). N-WASP, a novel
actin-depolymerizing protein, regulates the cortical cytoskeletalSupplementary Material
rearrangement in a PIP2-dependent manner downstream of ty-Supplementary Material including the Experimental Procedures for
rosine kinases. EMBO J. 15, 5326–5335.the present study and figures showing that expression of Type I
16. Halegoua, S. (1987). Changes in the phosphorylation and distri-PIPkinase induces cell rounding and detachment of PAE cells (Fig-
bution of vinculin during nerve growth factor induced neuriteure S1) and that the dominant-negative effect of kinase-dead Type
outgrowth. Dev. Biol. 121, 97–104.I PIPkinase on neurite outgrowth is suppressed by coexpression of
17. Varnum-Finney, B., and Reichardt, L.F. (1994). Vinculin-deficientwild-type Type I PIPkinase (Figure S2) is available at http://images.
PC12 cell lines extend unstable lamellipodia and filopodia andcellpress.com/supmat/supmatin.htm.
have a reduced rate of neurite outgrowth. J. Cell Biol. 127,
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